Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
LO2-H52H3 | Human | Human LOXL2 Protein, His Tag (active enzyme) | ![]() |
![]() ![]() |
|
LO2-H82E3 | Human | Biotinylated Human LOXL2 Protein, His,Avitag™ | ![]() |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
GB-2064 | PAT-1251; GB-2064 | Phase 2 Clinical | Pharmakea Inc | Polycythemia Vera; Primary Myelofibrosis; Thrombocythemia, Essential | Details |
PXS-5382 | PXS-5382; PXS-5382A | Phase 1 Clinical | Syntara Ltd | Metabolic Dysfunction-Associated Steatotic Liver Disease; Idiopathic Pulmonary Fibrosis; Renal fibrosis | Details |
PXS-5338 | PXS-5338 | Phase 1 Clinical | Syntara Ltd | Metabolic Dysfunction-Associated Steatotic Liver Disease; Liver Cirrhosis; Pulmonary Fibrosis; Renal fibrosis | Details |
This web search service is supported by Google Inc.